Expanding the horizon of CAR T cell therapy: from cancer treatment to autoimmune diseases and beyond

in Cancer Immunity and Immunotherapy

• Zishan Yang
• Bingjun Ha
• Qinhan Wu
• Feng Ren
• Zhinan Yin
• Hongru Zhang

A novel glycolysis-related gene signature for predicting prognosis and immunotherapy efficacy in breast cancer

in Cancer Immunity and Immunotherapy

• Rui Huang
• Yi Li
• Kaige Lin
• Luming Zheng
• Xiaoru Zhu
• Leqiu Huang
• Yunhan Ma

AI-enhanced profiling of phage-display-identified anti-TIM3 and anti-TIGIT novel antibodies

in Cancer Immunity and Immunotherapy

• Astrid Musnier
• Yannick Corde
• Adrien Verdier
• Mélanie Cortes
• Christophe Dumet
• Jean-René Pallandre
• Adeline Bouard
• Abdelraouf Keskes
• Zakaria Omahdi
• Vincent Puard

Integrative Analysis of Single-Cell and Bulk RNA Sequencing Reveals the Oncogenic Role of ANXA5 in Gastric Cancer and Its Association with Drug Resistance

in Cancer Immunity and Immunotherapy

• Denggang Chen
• Peng Zhang
• Li Gong
• Hailang Wei
• Chen Bai
• Tingting Zhang
• Guanghui Yu

Camrelizumab-based therapies for the treatment of advanced lung cancer: a prospective, open-label, multicenter, observational, real-world study

in Cancer Immunity and Immunotherapy

• Dong Zhao
• Minghong Bi
• Xiaofei Cheng
• Shuhong Wang
• Huaidong Cheng
• Xiaoyang Xia
• Huan Chen
• Yanbei Zhang
• Zhiqiang Hu
• Qisheng Cao

CD19 -targeted CAR T therapy treating Hematologic malignancies：hidden danger is the next neighbor to security？

in Cancer Immunity and Immunotherapy

• 学帅 叶
• min ge
• mengtian tan
• yongqiang wu
• haiqiang zhang

Similarities and differences of a proliferation-inducing ligand expression in lacrimal gland lesions of patients with IgG4-associated ophthalmic diseases and mucosa-associated lymphoid tissue lymphoma

in Cancer Immunity and Immunotherapy

• Lvfu He
• Lisha Zhan
• Yu Yang
• Weimin He

Polyamine metabolism and anti-tumor immunity

in Cancer Immunity and Immunotherapy

• Jing-Yi Wu
• Yan Zeng
• Yu-Yang You
• Qi-Yue Chen

Post-translational modifications in hepatocellular carcinoma: unlocking new frontiers in immunotherapy

in Cancer Immunity and Immunotherapy

• Yuexian Piao
• Naicui Zhai
• Xiaoling Zhang
• Wenjie Zhao
• Min Li

Combination of cadonilimab(PD-1/CTLA-4 Bispecific Antibody) and Apatinib as Salvage Therapy Achieves Partial Response in MSI-H Advanced Gastric Cancer：A case report

in Cancer Immunity and Immunotherapy

New hopes and challenges in targeted therapy and immunotherapy for primary central nervous system lymphoma

in Cancer Immunity and Immunotherapy

• Chuanwei Yang
• Xiaohui Ren
• Yong Cui
• Haihui Jiang
• Ming Li
• Kefu Yu
• Shaoping Shen
• Mingxiao Li
• Xiaokang Zhang
• Xuzhe Zhao

Predictors of severity and onset timing of immune-related adverse events in cancer patients receiving immune checkpoint inhibitors: a retrospective analysis

in Cancer Immunity and Immunotherapy

• Qimei Fang
• Yan Qian
• Zhaolu Xie
• Hongqiong Zhao
• Yang Zheng
• Di Li

Targeting stemness pathways modulates macrophage polarization and reprograms the tumor microenvironment

in Cancer Immunity and Immunotherapy

• Austėja Butkutė
• Marius Baltramonaitis
• Simona Malmige
• Adas Darinskas
• Vita Pasukoniene
• Agata Mlynska